跳至主要内容
临床试验/ISRCTN61735247
ISRCTN61735247已完成未知

Control of Hyperglycaemia In Paediatric intensive care

Royal Brompton & Harefiled NHS Trust (UK)0 个研究点目标入组 1,500 人开始时间: 2007年1月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Children from birth to 16 years who are undergoing intensive care treatment with an arterial line in-situ and receiving both mechanical ventilation and vasoactive support drugs following injury, major surgery or in association with critical illness in whom it is anticipated such treatment will be required to continue for at least 12 hours.

排除标准

  • 1. Children born pre-term and who are < 36 weeks corrected gestation
  • 2. Children with diabetes mellitus
  • 3. Children with an established or suspected diagnosis of an inborn error of metabolism
  • 4. Children for whom treatment withdrawal or limitation of intensive care treatment is being considered
  • 5. Children who have been in a PICU for more than 5 days in succession
  • 6. Children admitted to a PICU who have already participated in the CHIP study during a previous PICU admission

研究者

发起方
Royal Brompton & Harefiled NHS Trust (UK)

相似试验

Control of hyperglycaemia in paediatric intensive... | 临床试验